Nevro Plans to Unveil Third-Quarter Financial Results
Nevro Corp. (NYSE: NVRO), a prominent global medical device company, is gearing up for an important event in its fiscal calendar. The firm will announce its financial results for the third quarter of 2024 following the market's closure. This highly anticipated update will be available on November 11, 2024. To enhance communication with stakeholders, Nevro will hold a conference call where participants can delve into the details of the quarterly results.
Conference Call Details for Investors
The conference call is set to commence at 1:30 p.m. PST (4:30 p.m. EST), providing an open forum for discussion about the company's performance and updates. Investors will gain insights into how Nevro’s innovative solutions are progressing in the market. Additionally, a live webcast of the call will be available on the Investor Relations section of Nevro's official website, allowing for easy access to listeners worldwide.
Accessibility for Participants
For those without internet access, telephonic participation is possible. Interested parties can join the call by dialing one of the provided numbers. Domestic participants can call the toll-free number 1-(888) 596-4144, while international participants can connect at 1-(646) 968-2525. It’s necessary to use the conference ID 5980028 to gain entry to the call.
Understanding Nevro's Mission and Solutions
Headquartered in Redwood City, California, Nevro is dedicated to offering comprehensive, life-altering solutions for chronic pain. Their flagship innovation, the proprietary 10 kHz Therapy™, is evidence-based and non-pharmacologic, impacting over 115,000 patients worldwide positively. The company's HFX™ spinal cord stimulation (SCS) platform, which includes the Senza SCS system, addresses chronic pain conditions effectively.
Recent Advancements in Treatment Options
Nevro has recently introduced a minimally invasive treatment solution targeting chronic sacroiliac joint (SI joint) pain. This addition strengthens their portfolio, making it one of the most comprehensive in the SI joint fusion market. By offering various products, the company aims to meet the preferences of both physicians and patients, ensuring better outcomes and improved quality of life.
The Unique Offerings from Nevro
The Senza, Senza II, Senza Omnia, and HFX iQ systems are designed to deliver the renowned 10 kHz Therapy. Alongside innovative products, Nevro provides dedicated support services that ensure each patient has access to an HFX Coach throughout their recovery process. Additionally, physicians benefit from Nevrocloud insights to enhance patient management and practice efficiency.
Engaging with Nevro
The public can engage with Nevro through various channels. They can explore recent advancements and updates on their innovative products via Nevro’s social media platforms and website, where numerous resources are available. Nevro continues to make strides in its mission to help patients live pain-free lives while fostering a strong connection with its community.
Frequently Asked Questions
What are the main highlights of Nevro's upcoming financial report?
Nevro's financial report will provide insights into their performance and strategic advancements made during Q3 of 2024.
How can I participate in the Nevro conference call?
Participants can join via the web or phone using the provided dial-in numbers and conference ID.
What products does Nevro currently offer?
Nevro offers a range of products including the Senza and HFX systems, which integrate the proprietary 10 kHz Therapy.
What recent innovations has Nevro introduced?
Nevro has recently added a minimally invasive treatment option for chronic SI joint pain.
How does Nevro support its patients?
The company provides patients with dedicated coaches throughout their pain management journey, ensuring comprehensive support.
